Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Oct 2;9(6):2230–2240. doi: 10.1002/epi4.13045

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 The Author(s). Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.

This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Incidence of weight change and appetite–related TEAEs during the BRV treatment period (SS).^a BRV, brivaracetam; SS, safety set; TEAE, treatment‐emergent adverse event. ^aFigure presents the number of patients reporting TEAEs with a start date within the specified 3‐month time interval. Patients were included in a 3‐month interval if they were receiving BRV at any time during that interval. One month was defined as 30 days. No weight change or appetite–related TEAEs were reported after month 87.